Kathryn Eve Lewandowski, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychotic Disorders | 31 | 2023 | 3046 | 4.420 |
Why?
|
Bipolar Disorder | 29 | 2022 | 5027 | 3.170 |
Why?
|
Schizophrenia | 30 | 2022 | 6882 | 2.640 |
Why?
|
Cognition Disorders | 14 | 2020 | 4041 | 2.040 |
Why?
|
Affective Disorders, Psychotic | 3 | 2019 | 191 | 1.340 |
Why?
|
Schizophrenic Psychology | 12 | 2018 | 1678 | 1.240 |
Why?
|
Social Behavior | 2 | 2020 | 1127 | 0.760 |
Why?
|
Neuropsychological Tests | 8 | 2020 | 6991 | 0.760 |
Why?
|
Prefrontal Cortex | 3 | 2019 | 2148 | 0.640 |
Why?
|
Emotional Intelligence | 1 | 2019 | 135 | 0.600 |
Why?
|
Cognition | 15 | 2022 | 6765 | 0.600 |
Why?
|
Nerve Net | 2 | 2019 | 2175 | 0.560 |
Why?
|
Independent Living | 1 | 2020 | 568 | 0.530 |
Why?
|
Schizotypal Personality Disorder | 3 | 2018 | 288 | 0.470 |
Why?
|
Therapy, Computer-Assisted | 1 | 2016 | 277 | 0.470 |
Why?
|
Neuroglia | 1 | 2019 | 927 | 0.460 |
Why?
|
Behavior Therapy | 1 | 2017 | 867 | 0.390 |
Why?
|
Consensus | 2 | 2017 | 2958 | 0.390 |
Why?
|
Gyrus Cinguli | 1 | 2017 | 1091 | 0.370 |
Why?
|
Hallucinations | 2 | 2011 | 360 | 0.370 |
Why?
|
Psychiatric Status Rating Scales | 7 | 2018 | 6037 | 0.330 |
Why?
|
Catechol O-Methyltransferase | 2 | 2007 | 245 | 0.320 |
Why?
|
DiGeorge Syndrome | 2 | 2007 | 177 | 0.320 |
Why?
|
Computer-Assisted Instruction | 1 | 2010 | 365 | 0.300 |
Why?
|
Schizophrenia, Childhood | 1 | 2007 | 6 | 0.300 |
Why?
|
Smell | 1 | 2009 | 244 | 0.290 |
Why?
|
Young Adult | 18 | 2023 | 56436 | 0.290 |
Why?
|
Touch | 1 | 2009 | 306 | 0.290 |
Why?
|
Axons | 1 | 2015 | 1686 | 0.290 |
Why?
|
Learning | 1 | 2016 | 1713 | 0.280 |
Why?
|
Disease Progression | 2 | 2013 | 13280 | 0.260 |
Why?
|
Brain | 7 | 2023 | 26413 | 0.260 |
Why?
|
Adult | 26 | 2020 | 214035 | 0.250 |
Why?
|
Social Support | 1 | 2015 | 2117 | 0.250 |
Why?
|
Humans | 57 | 2023 | 744220 | 0.250 |
Why?
|
Aspartic Acid | 2 | 2019 | 576 | 0.250 |
Why?
|
Social Adjustment | 3 | 2017 | 631 | 0.230 |
Why?
|
Chromosomes, Human, Pair 22 | 4 | 2010 | 351 | 0.230 |
Why?
|
Cerebral Cortex | 2 | 2022 | 5709 | 0.220 |
Why?
|
Male | 31 | 2020 | 350027 | 0.210 |
Why?
|
Psychometrics | 3 | 2012 | 3002 | 0.200 |
Why?
|
Female | 30 | 2020 | 380197 | 0.190 |
Why?
|
Choroid Plexus | 1 | 2023 | 231 | 0.180 |
Why?
|
Cluster Analysis | 3 | 2017 | 2715 | 0.180 |
Why?
|
Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 15 | 0.180 |
Why?
|
Glycine Agents | 1 | 2019 | 17 | 0.170 |
Why?
|
Chromosome Deletion | 4 | 2010 | 1401 | 0.170 |
Why?
|
Diffusion Tensor Imaging | 3 | 2019 | 2305 | 0.160 |
Why?
|
Adolescent | 14 | 2018 | 85759 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 10 | 2023 | 35423 | 0.150 |
Why?
|
Choline | 1 | 2019 | 493 | 0.150 |
Why?
|
Nootropic Agents | 1 | 2018 | 160 | 0.150 |
Why?
|
Creatine | 1 | 2019 | 421 | 0.150 |
Why?
|
Mental Recall | 1 | 2023 | 1205 | 0.150 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 933 | 0.150 |
Why?
|
Perceptual Disorders | 1 | 2018 | 196 | 0.140 |
Why?
|
Multifactorial Inheritance | 2 | 2022 | 1194 | 0.140 |
Why?
|
Analysis of Variance | 3 | 2015 | 6367 | 0.140 |
Why?
|
Glycine | 1 | 2019 | 671 | 0.130 |
Why?
|
Thalamus | 1 | 2021 | 1024 | 0.130 |
Why?
|
Myelin Sheath | 1 | 2019 | 655 | 0.130 |
Why?
|
Middle Aged | 14 | 2018 | 213367 | 0.130 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2691 | 0.120 |
Why?
|
Aging | 1 | 2013 | 8661 | 0.120 |
Why?
|
Reward | 1 | 2020 | 941 | 0.120 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 895 | 0.120 |
Why?
|
Parietal Lobe | 1 | 2019 | 838 | 0.120 |
Why?
|
Auditory Perception | 1 | 2018 | 569 | 0.110 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 894 | 0.110 |
Why?
|
Anxiety | 2 | 2012 | 4297 | 0.110 |
Why?
|
Psychopathology | 2 | 2019 | 409 | 0.110 |
Why?
|
Severity of Illness Index | 5 | 2018 | 15538 | 0.100 |
Why?
|
Remedial Teaching | 1 | 2010 | 13 | 0.100 |
Why?
|
Frontal Lobe | 2 | 2016 | 1407 | 0.100 |
Why?
|
Affect | 1 | 2019 | 1475 | 0.100 |
Why?
|
Motivation | 1 | 2020 | 1971 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2020 | 5076 | 0.090 |
Why?
|
Quality of Life | 3 | 2022 | 12805 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1462 | 0.090 |
Why?
|
Visual Perception | 1 | 2018 | 1420 | 0.090 |
Why?
|
Delusions | 1 | 2011 | 300 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2019 | 3760 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2019 | 21752 | 0.080 |
Why?
|
Antipsychotic Agents | 2 | 2018 | 3058 | 0.080 |
Why?
|
Neuronal Plasticity | 1 | 2016 | 1422 | 0.070 |
Why?
|
Age Factors | 2 | 2015 | 18367 | 0.070 |
Why?
|
Psychotherapy, Group | 1 | 2010 | 407 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19907 | 0.070 |
Why?
|
Genetic Counseling | 1 | 2010 | 600 | 0.070 |
Why?
|
Evoked Potentials, Auditory | 2 | 2021 | 525 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3888 | 0.070 |
Why?
|
Personality | 1 | 2010 | 552 | 0.070 |
Why?
|
Massachusetts | 2 | 2016 | 8663 | 0.070 |
Why?
|
Depression | 1 | 2006 | 7767 | 0.070 |
Why?
|
Mood Disorders | 2 | 2022 | 1106 | 0.070 |
Why?
|
Intelligence | 2 | 2007 | 920 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2015 | 2708 | 0.060 |
Why?
|
Family | 1 | 2014 | 3148 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3063 | 0.060 |
Why?
|
Residence Characteristics | 1 | 2013 | 2050 | 0.060 |
Why?
|
Factor Analysis, Statistical | 1 | 2006 | 977 | 0.060 |
Why?
|
Personality Inventory | 1 | 2006 | 1030 | 0.050 |
Why?
|
Linear Models | 1 | 2013 | 5953 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7908 | 0.050 |
Why?
|
Models, Psychological | 1 | 2007 | 811 | 0.050 |
Why?
|
Cadmium | 1 | 2023 | 212 | 0.050 |
Why?
|
Psychotherapy | 1 | 2010 | 1645 | 0.050 |
Why?
|
Social Class | 1 | 2010 | 1999 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2012 | 1953 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2018 | 4645 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15070 | 0.050 |
Why?
|
Dopamine | 1 | 2007 | 1591 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.040 |
Why?
|
Neurons | 1 | 2019 | 9335 | 0.040 |
Why?
|
Memory Disorders | 1 | 2007 | 1184 | 0.040 |
Why?
|
Models, Neurological | 1 | 2007 | 1775 | 0.040 |
Why?
|
Cerebellum | 2 | 2021 | 1490 | 0.040 |
Why?
|
Interview, Psychological | 2 | 2012 | 812 | 0.040 |
Why?
|
Aged | 4 | 2019 | 163253 | 0.040 |
Why?
|
Attention | 1 | 2007 | 2399 | 0.030 |
Why?
|
Rabbits | 1 | 2022 | 4892 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39045 | 0.030 |
Why?
|
Space Perception | 1 | 2018 | 475 | 0.030 |
Why?
|
Risk Factors | 2 | 2016 | 72280 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1791 | 0.030 |
Why?
|
Comorbidity | 3 | 2015 | 10387 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2427 | 0.030 |
Why?
|
Motion Perception | 1 | 2018 | 408 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23337 | 0.030 |
Why?
|
Social Work | 1 | 2015 | 162 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40063 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2015 | 421 | 0.030 |
Why?
|
Endophenotypes | 1 | 2014 | 250 | 0.030 |
Why?
|
Pattern Recognition, Visual | 1 | 2018 | 824 | 0.030 |
Why?
|
United States | 1 | 2020 | 69867 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2018 | 975 | 0.030 |
Why?
|
Cohort Studies | 2 | 2018 | 40559 | 0.030 |
Why?
|
Neural Pathways | 1 | 2021 | 2972 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1537 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1940 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5252 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2016 | 63119 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3478 | 0.020 |
Why?
|
Panic Disorder | 1 | 2012 | 616 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6485 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3749 | 0.020 |
Why?
|
Child | 4 | 2010 | 77679 | 0.020 |
Why?
|
Electroencephalography | 1 | 2021 | 6150 | 0.020 |
Why?
|
Child Behavior Disorders | 1 | 2010 | 807 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12035 | 0.020 |
Why?
|
Patient Care Team | 1 | 2015 | 2529 | 0.020 |
Why?
|
Septum Pellucidum | 1 | 2004 | 58 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2374 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 25043 | 0.010 |
Why?
|
Cephalometry | 1 | 2004 | 382 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12961 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2004 | 737 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2015 | 4259 | 0.010 |
Why?
|
Syndrome | 1 | 2004 | 3250 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2004 | 1416 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4328 | 0.010 |
Why?
|
Alleles | 1 | 2006 | 6938 | 0.010 |
Why?
|
Risk | 1 | 2004 | 9685 | 0.010 |
Why?
|
Genotype | 1 | 2006 | 12956 | 0.010 |
Why?
|
Animals | 1 | 2022 | 168788 | 0.010 |
Why?
|